08:17 AM EDT, 03/27/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Thursday that the Japanese Ministry of Health, Labor and Welfare has approved acoramidis, under the brand name Beyonttra, to treat adults with transthyretin-mediated amyloid cardiomyopathy, a heart condition caused by abnormal deposits of the transthyretin protein in the heart muscle. The biopharmaceutical company said the approval is...

08:18 AM EDT, 03/27/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications. The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome...

08:18 AM EDT, 03/27/2025 (MT Newswires) -- Clean Energy Fuels ( CLNE ) said Thursday its board has decided to resume share buybacks under its existing share repurchase program. Capacity for repurchases under the program, which started in March 2020, was boosted to $50 million in December 2021. About $26.5 million of capacity remains under the program. ...

08:18 AM EDT, 03/27/2025 (MT Newswires) -- Generation Mining ( GENMF ) reported Thursday the results of an updated feasibility study for the Marathon copper-palladium project in Ontario. The study generated a base case after-tax net present value of $1.07 billion at a 6% discount, with a 28% internal rate of return and a 1.9-year payback period. Initial capital was...